Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market. "We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it." 23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."

Share:
More In Technology
Medable Secures $304M in Series D Funding
Clinical research company Medable has secured $304 million in Series D funding, marking its fourth round since 2020, giving the firm a valuation of just over $2 billion. Dr. Michelle Longmire, CEO and Co-founder, Medable joined Cheddar's Opening Bell to discuss the future of the company.
Sportradar Lands Major Soccer Deal as Sports Betting Explodes
Sportradar, a global sports data company, announced it will serve as UEFA’s exclusive authorized collector and distributor of data for betting purposes. The agreement covers 1,550 matches from the 2021-2022 season through to the end of the 2023-2024 season across all UEFA properties in Europe. Sportradar CEO Carsten Koerl joined Cheddar to provide additional details on the landmark partnership and some insight into the future of sports betting.
Climate Summit, Rittenhouse Trial & Traffic Deaths
Carlo's flying solo today, talking COP26 and climate change, another racially charged trial gets underway, SCOTUS takes on abortion and a stunning rise in traffic deaths points to a bigger societal breakdown sparked by the pandemic.
Load More